Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)

Study Groups:

If you are found to be eligible to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 study groups. This is done because no one knows if one group is the same, better, or worse than the other group.

• If you are assigned to Group 1, you will receive standard enhanced care after your surgery.
• If you are assigned to Group 2, you will receive routine care after surgery, but you will also receive accelerated recovery, early discharge, and Telemedicine. Participants will be loaned an iPad to use for video-conferencing and text messaging in this study.

This is an investigational study. The study doctor can explain how RecoverMI is designed to work.

Up to 32 participants will be enrolled in this study. All will take part at MD Anderson.

Inclusion criteria

• Patient has histologically proven colorectal cancer or polyp(s) that is planned to be treated by surgical resection performed with curative intent.
• Patient is >/= 18 years and younger than 80 years.
• Elective minimally invasive operation.
• No planned ostomy creation at time of enrollment.
• Serum creatinine <1.5 measured within 30 days of surgery.
• Ability to speak, read, and understand English.

Exclusion criteria

• Strong, self-reported history of postoperative nausea and vomiting.
• History of congestive heart failure. Systolic heart failure defined as Ejection Fraction (EF) </= 40%), or diastolic heart failure defined as EF >40% PLUS systemic manifestation of heart failure.